Prime Highlights
- Flagler Health raised $50 million in Series B funding led by Bessemer Venture Partners.
- The platform generates an average of $164,000 in additional annual revenue per MSK provider.
Key Facts
- Flagler Health is an AI-native platform built for musculoskeletal care, integrating with existing EMRs and clinic workflows.
- MSK conditions affect over half of US adults and account for more than $400 billion in annual healthcare spend.
Background
Artificial intelligence platform Flagler Health has raised $50 million in a Series B funding round to expand its AI-native operating system for musculoskeletal (MSK) care. The company announced the raise in the second week of August.
SignalFire, Alumni Ventures, Streamlined, 186 Ventures, Proof VC, Tribeca Ventures, and Offscript participated in the round, which was headed by Bessemer Venture Partners. Bessemer partner Steve Kraus said the firm was drawn to Flagler’s founding team, which combines healthcare operations experience, clinical authority and AI expertise, applied to one of healthcare’s largest underserved markets. He described Flagler as the only full-stack platform created especially for MSK care, pointing out the company’s growth and returns in less than three years.
Over half of US individuals suffer from musculoskeletal disorders, which cost the country’s healthcare system more than $400 billion annually, despite the inefficiency of care delivery. The company said physicians spend nearly 75% of their time on administrative work rather than revenue-generating tasks.
Flagler’s platform integrates with existing electronic medical records and manages the full patient journey, from triage to billing and communications. It has scaled to thousands of MSK providers across more than 36 states, generating an average of $164,000 in extra annual revenue per provider, while 87% of patients report improved pain, mood, sleep or mobility.
Coastal Health physician Christopher Netzel said the platform tracks patient outcomes remotely without requiring any change to existing workflows.
CEO Albert Katz said MSK care reflects the healthcare system’s dysfunction most visibly, driven by shrinking reimbursements and administrative overload, and said Flagler aims to fix the problem at its root. The company plans to use the funding to expand across MSK practices nationwide.
